Rani A Sarkis, Janet Orozco, Hernan Nicolas Lemus, Alexis Hankerson, Lei Liu, Alice D Lam, Emily Johnson, Steven Stufflebeam, Anand Viswanathan, Rebecca E Amariglio, Mallika Purandare, Patrick Trouten, Geoffrey S Young, Joseph J Locascio, Page B Pennell, Gad A Marshall
{"title":"迟发性不明原因癫痫发作与认知障碍和杏仁核体积降低有关。","authors":"Rani A Sarkis, Janet Orozco, Hernan Nicolas Lemus, Alexis Hankerson, Lei Liu, Alice D Lam, Emily Johnson, Steven Stufflebeam, Anand Viswanathan, Rebecca E Amariglio, Mallika Purandare, Patrick Trouten, Geoffrey S Young, Joseph J Locascio, Page B Pennell, Gad A Marshall","doi":"10.1093/braincomms/fcaf050","DOIUrl":null,"url":null,"abstract":"<p><p>Late-onset epilepsy has been linked with accelerated cognitive decline and a higher risk of dementia. In this study, we sought to characterize the cognitive profile of participants with late-onset unexplained epilepsy and compare their MRI findings to healthy controls, to better understand underlying disease mechanisms. We recruited participants with at least one new-onset unexplained seizure at age 55 or later, without cortical lesions on MRI, within 5 years of the first seizure. We administered a neuropsychological battery to generate Preclinical Alzheimer Cognitive Composite and composite scores for delayed verbal recall, processing speed and executive function. We held a consensus meeting to determine whether the participants fulfilled criteria for mild cognitive impairment. An MRI volumetric analysis of hippocampal, amygdalae, and white matter hyperintensity volume was performed and compared to 353 healthy controls from the Harvard Aging Brain Study. On late-onset unexplained epilepsy participants, we also obtained 24-h EEG recording. Seventy participants were recruited, mean age 71.0 ± 7.0 years, 49% female, 15.6 ± 3.0 years of education. Impaired cognition (<i>z</i>-score ≤ -1.5) for late-onset unexplained epilepsy included the following: 15.9% for Preclinical Alzheimer Cognitive Composite -5, 23.2% for delayed verbal recall, 15.6% for processing speed and 7.5% for executive function. Seventeen percent were found to have mild cognitive impairment. Late-onset unexplained epilepsy participants who were drug resistant were more likely to have cognitive impairment (50% vs. 9%). When controlling for age, sex and race, late-onset unexplained epilepsy group had lower left AV (%; β = -0.003, <i>P</i> = 0.0016), right AV (%) (β = -0.003, <i>P</i> = 0.01), and log-transformed WMV (mm<sup>3</sup>; β = -0.21, <i>P</i> = 0.03) compared with Harvard Aging Brain Study (HABS); there were no differences in left or right HV between groups. EEG captured epileptiform abnormalities in 49% late-onset unexplained epilepsy participants, with a left temporal predominance (54%). In this single-site study of prospectively enrolled participants with late-onset unexplained epilepsy, we show that individuals with late-onset unexplained epilepsy exhibit cognitive impairments, mostly in verbal memory, and temporal dysfunction with left-sided predominance. Neuroimaging, when compared with healthy controls, shows lower amygdalae and white matter hyperintensity but not hippocampal volumes suggesting that the amygdalae is one of the earliest sites involved in the disease. The results also highlight the importance of seizure control given the association between mild cognitive impairment and drug-resistant epilepsy. Future studies extending these findings to Alzheimer's disease biomarkers and longitudinal follow-up will inform predictors of cognitive decline.</p>","PeriodicalId":93915,"journal":{"name":"Brain communications","volume":"7 1","pages":"fcaf050"},"PeriodicalIF":4.5000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11815171/pdf/","citationCount":"0","resultStr":"{\"title\":\"Late-onset unexplained seizures are associated with cognitive impairment and lower amygdala volumes.\",\"authors\":\"Rani A Sarkis, Janet Orozco, Hernan Nicolas Lemus, Alexis Hankerson, Lei Liu, Alice D Lam, Emily Johnson, Steven Stufflebeam, Anand Viswanathan, Rebecca E Amariglio, Mallika Purandare, Patrick Trouten, Geoffrey S Young, Joseph J Locascio, Page B Pennell, Gad A Marshall\",\"doi\":\"10.1093/braincomms/fcaf050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Late-onset epilepsy has been linked with accelerated cognitive decline and a higher risk of dementia. In this study, we sought to characterize the cognitive profile of participants with late-onset unexplained epilepsy and compare their MRI findings to healthy controls, to better understand underlying disease mechanisms. We recruited participants with at least one new-onset unexplained seizure at age 55 or later, without cortical lesions on MRI, within 5 years of the first seizure. We administered a neuropsychological battery to generate Preclinical Alzheimer Cognitive Composite and composite scores for delayed verbal recall, processing speed and executive function. We held a consensus meeting to determine whether the participants fulfilled criteria for mild cognitive impairment. An MRI volumetric analysis of hippocampal, amygdalae, and white matter hyperintensity volume was performed and compared to 353 healthy controls from the Harvard Aging Brain Study. On late-onset unexplained epilepsy participants, we also obtained 24-h EEG recording. Seventy participants were recruited, mean age 71.0 ± 7.0 years, 49% female, 15.6 ± 3.0 years of education. Impaired cognition (<i>z</i>-score ≤ -1.5) for late-onset unexplained epilepsy included the following: 15.9% for Preclinical Alzheimer Cognitive Composite -5, 23.2% for delayed verbal recall, 15.6% for processing speed and 7.5% for executive function. Seventeen percent were found to have mild cognitive impairment. Late-onset unexplained epilepsy participants who were drug resistant were more likely to have cognitive impairment (50% vs. 9%). When controlling for age, sex and race, late-onset unexplained epilepsy group had lower left AV (%; β = -0.003, <i>P</i> = 0.0016), right AV (%) (β = -0.003, <i>P</i> = 0.01), and log-transformed WMV (mm<sup>3</sup>; β = -0.21, <i>P</i> = 0.03) compared with Harvard Aging Brain Study (HABS); there were no differences in left or right HV between groups. EEG captured epileptiform abnormalities in 49% late-onset unexplained epilepsy participants, with a left temporal predominance (54%). In this single-site study of prospectively enrolled participants with late-onset unexplained epilepsy, we show that individuals with late-onset unexplained epilepsy exhibit cognitive impairments, mostly in verbal memory, and temporal dysfunction with left-sided predominance. Neuroimaging, when compared with healthy controls, shows lower amygdalae and white matter hyperintensity but not hippocampal volumes suggesting that the amygdalae is one of the earliest sites involved in the disease. The results also highlight the importance of seizure control given the association between mild cognitive impairment and drug-resistant epilepsy. Future studies extending these findings to Alzheimer's disease biomarkers and longitudinal follow-up will inform predictors of cognitive decline.</p>\",\"PeriodicalId\":93915,\"journal\":{\"name\":\"Brain communications\",\"volume\":\"7 1\",\"pages\":\"fcaf050\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11815171/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/braincomms/fcaf050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/braincomms/fcaf050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
迟发性癫痫与认知能力加速下降和痴呆风险增加有关。在这项研究中,我们试图描述迟发性不明原因癫痫患者的认知特征,并将他们的MRI结果与健康对照进行比较,以更好地了解潜在的疾病机制。我们招募了年龄在55岁或更晚,在第一次癫痫发作后5年内至少有一次新发不明原因癫痫发作,MRI检查无皮层病变的参与者。我们使用神经心理学测试来生成临床前阿尔茨海默氏认知综合评分和延迟言语回忆、处理速度和执行功能的综合评分。我们召开了一次共识会议,以确定参与者是否符合轻度认知障碍的标准。对海马体、杏仁体和白质高强度体积进行了MRI体积分析,并与来自哈佛衰老脑研究的353名健康对照进行了比较。对于迟发性不明原因癫痫患者,我们也获得了24小时脑电图记录。纳入70例,平均年龄71.0±7.0岁,女性49%,文化程度15.6±3.0年。迟发性不明原因癫痫的认知障碍(z-score≤-1.5)包括:临床前阿尔茨海默认知复合-5为15.9%,延迟言语回忆为23.2%,加工速度为15.6%,执行功能为7.5%。17%的人有轻度认知障碍。耐药的迟发性不明原因癫痫患者更有可能出现认知障碍(50%对9%)。在控制年龄、性别和种族的情况下,迟发性不明原因癫痫组左室电位较低(%;β = -0.003, P = 0.0016),右AV (%) (β = -0.003, P = 0.01),对数变换WMV (mm3;β = -0.21, P = 0.03),与哈佛老化脑研究(HABS)比较;左、右HV组间无差异。在49%的迟发性不明原因癫痫患者中,脑电图捕捉到癫痫样异常,其中左侧颞叶占优势(54%)。在这项对迟发性不明原因癫痫患者的前瞻性单点研究中,我们发现迟发性不明原因癫痫患者表现出认知障碍,主要是言语记忆,以及以左侧为主的颞功能障碍。与健康对照组相比,神经成像显示杏仁体和白质的高密度较低,但海马的体积没有下降,这表明杏仁体是该疾病最早涉及的部位之一。研究结果还强调了癫痫发作控制的重要性,因为轻度认知障碍和耐药性癫痫之间存在关联。未来的研究将这些发现扩展到阿尔茨海默病的生物标志物和纵向随访,将为认知能力下降的预测提供信息。
Late-onset unexplained seizures are associated with cognitive impairment and lower amygdala volumes.
Late-onset epilepsy has been linked with accelerated cognitive decline and a higher risk of dementia. In this study, we sought to characterize the cognitive profile of participants with late-onset unexplained epilepsy and compare their MRI findings to healthy controls, to better understand underlying disease mechanisms. We recruited participants with at least one new-onset unexplained seizure at age 55 or later, without cortical lesions on MRI, within 5 years of the first seizure. We administered a neuropsychological battery to generate Preclinical Alzheimer Cognitive Composite and composite scores for delayed verbal recall, processing speed and executive function. We held a consensus meeting to determine whether the participants fulfilled criteria for mild cognitive impairment. An MRI volumetric analysis of hippocampal, amygdalae, and white matter hyperintensity volume was performed and compared to 353 healthy controls from the Harvard Aging Brain Study. On late-onset unexplained epilepsy participants, we also obtained 24-h EEG recording. Seventy participants were recruited, mean age 71.0 ± 7.0 years, 49% female, 15.6 ± 3.0 years of education. Impaired cognition (z-score ≤ -1.5) for late-onset unexplained epilepsy included the following: 15.9% for Preclinical Alzheimer Cognitive Composite -5, 23.2% for delayed verbal recall, 15.6% for processing speed and 7.5% for executive function. Seventeen percent were found to have mild cognitive impairment. Late-onset unexplained epilepsy participants who were drug resistant were more likely to have cognitive impairment (50% vs. 9%). When controlling for age, sex and race, late-onset unexplained epilepsy group had lower left AV (%; β = -0.003, P = 0.0016), right AV (%) (β = -0.003, P = 0.01), and log-transformed WMV (mm3; β = -0.21, P = 0.03) compared with Harvard Aging Brain Study (HABS); there were no differences in left or right HV between groups. EEG captured epileptiform abnormalities in 49% late-onset unexplained epilepsy participants, with a left temporal predominance (54%). In this single-site study of prospectively enrolled participants with late-onset unexplained epilepsy, we show that individuals with late-onset unexplained epilepsy exhibit cognitive impairments, mostly in verbal memory, and temporal dysfunction with left-sided predominance. Neuroimaging, when compared with healthy controls, shows lower amygdalae and white matter hyperintensity but not hippocampal volumes suggesting that the amygdalae is one of the earliest sites involved in the disease. The results also highlight the importance of seizure control given the association between mild cognitive impairment and drug-resistant epilepsy. Future studies extending these findings to Alzheimer's disease biomarkers and longitudinal follow-up will inform predictors of cognitive decline.